Variation of blood T lymphocyte subgroups in patients with non- small cell lung cancer

41Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Objectives: To study variation in T lymphocyte subgoups and its clinical significance in non-small cell lung cancer (NSCLC). Methods: Levels of CD3+ , CD4+ , CD8+ , CD4+/CD8+, NK and Treg cells in peripheral blood of NSCLC cases and healthy adults were determined by flow cytometry. Results: CD3+ , CD4+ and CD4+/CD8+ ratio and NK cells in NSCLCs were decreased significantly in comparison with the control group (P < 0.01), and decreased with increase in the clinical stage of NSCLC, while CD8+ cells demonstrated no significant change (P > 0.05). Treg cells were significantly more frequent than in the control group (P < 0.01), and increased with the clinical stage of NSCLC. Conclusion: The cellular immune function of the NSCLC patients is lowered. It is important to detect change of T lymphocyte subgroups by flow cytometry for the diagnosis, treatment and prognostic assessment of NSCLC patients.

Cite

CITATION STYLE

APA

Wang, W. J., Tao, Z., Gu, W., & Sun, L. H. (2013). Variation of blood T lymphocyte subgroups in patients with non- small cell lung cancer. Asian Pacific Journal of Cancer Prevention, 14(8), 4671–4673. https://doi.org/10.7314/APJCP.2013.14.8.4671

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free